| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 90.24B | 88.48B | 82.84B | 78.44B | 67.09B | 65.26B |
| Gross Profit | 19.59B | 18.96B | 17.79B | 15.84B | 12.71B | 13.66B |
| EBITDA | 9.56B | 9.10B | 8.70B | 7.44B | 5.81B | 6.69B |
| Net Income | 5.22B | 4.78B | 4.34B | 4.27B | 2.68B | 4.08B |
Balance Sheet | ||||||
| Total Assets | 131.36B | 130.28B | 130.79B | 114.52B | 99.49B | 92.79B |
| Cash, Cash Equivalents and Short-Term Investments | 10.65B | 12.88B | 10.65B | 11.13B | 12.94B | 12.69B |
| Total Debt | 36.77B | 36.16B | 39.40B | 31.08B | 24.63B | 19.72B |
| Total Liabilities | 63.23B | 61.44B | 65.49B | 54.95B | 44.55B | 40.80B |
| Stockholders Equity | 67.91B | 68.61B | 65.03B | 59.18B | 54.51B | 51.61B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 7.46B | -7.84B | -8.13B | -4.62B | -1.65B |
| Operating Cash Flow | 0.00 | 9.43B | -4.59B | -5.69B | -3.44B | 690.07M |
| Investing Cash Flow | 0.00 | -2.02B | -2.23B | -2.06B | -1.08B | -2.38B |
| Financing Cash Flow | 0.00 | -5.59B | 5.87B | 5.10B | 4.15B | 3.54B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥81.20B | 136.93 | 5.02% | 3.23% | -10.00% | -51.92% | |
78 Outperform | ¥114.14B | 12.40 | ― | 3.24% | 18.70% | 33.93% | |
75 Outperform | ¥64.75B | 13.24 | ― | 3.95% | -1.67% | -4.39% | |
74 Outperform | ¥75.71B | 14.21 | 9.39% | 1.68% | 9.27% | 69.52% | |
74 Outperform | ¥22.80B | 46.66 | ― | 2.77% | -4.47% | -24.47% | |
65 Neutral | ¥18.69B | 10.67 | ― | ― | -2.84% | ― | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |